- Conditions
- Charcot-Marie-Tooth Disease
- Interventions
- FLX-787-ODT (orally disintegrating tablet), Placebo ODT
- Drug
- Lead sponsor
- Flex Pharma, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 20
- States / cities
- Scottsdale, Arizona • Aurora, Colorado • New Britain, Connecticut + 16 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 30
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Breast - Female
- Interventions
- Transversus Abdominis Plane (TAP) block, Nimbus Infusion Pump IV Administration, Bupivacaine infusion, Acetominophen, Hydromorphone, Oxycodone, Ondansetron
- Procedure · Device · Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2021
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder
- Interventions
- Amphetamine, ESDM informed parent coaching, Placebo Oral Tablet
- Drug · Behavioral
- Lead sponsor
- Duke University
- Other
- Eligibility
- 36 Months to 131 Months
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Migraine
- Interventions
- Rimegepant, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 962 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 23
- States / cities
- Los Angeles, California • Sherman Oaks, California • Stamford, Connecticut + 20 more
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- ADZENYS XR-ODT, Placebo Oral Tablet
- Drug
- Lead sponsor
- Aytu BioPharma, Inc.
- Industry
- Eligibility
- 4 Years to 5 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2025
- U.S. locations
- 1
- States / cities
- Las Vegas, Nevada
- Conditions
- Nocturia
- Interventions
- FE 201836, Desmopressin, Placebo oral solution, Placebo ODT
- Drug
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 302 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 43
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Lincoln, California + 35 more
- Conditions
- Migraine, With or Without Aura
- Interventions
- Rimegepant, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,811 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 69
- States / cities
- Mobile, Alabama • Tempe, Arizona • Tucson, Arizona + 61 more
- Conditions
- Preventive Treatment of Migraine
- Interventions
- Rimegepant, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 4
- States / cities
- Canoga Park, California • Boca Raton, Florida • Papillion, Nebraska + 1 more
- Conditions
- Eosinophilic Esophagitis
- Interventions
- APT-1011, Placebo
- Drug
- Lead sponsor
- Adare Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 106 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 51
- States / cities
- Chandler, Arizona • Tucson, Arizona • Sherwood, Arkansas + 45 more
- Conditions
- Migraine
- Interventions
- Rimegepant, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 6 Years to 17 Years
- Enrollment
- 640 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2032
- U.S. locations
- 56
- States / cities
- Fort Smith, Arkansas • Hawthorne, California • La Mesa, California + 42 more
- Conditions
- Migraine
- Interventions
- Rimegepant, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 813 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 23
- States / cities
- Los Angeles, California • Stamford, Connecticut • Lake City, Florida + 20 more
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Rimegepant 75 MG [Nurtec]
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 39 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Pain, Postoperative
- Interventions
- CBD Oral Disintegrating Tablet (ODT), Placebo ODT
- Drug · Other
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Temporomandibular Disorders (TMD)
- Interventions
- Rimegepant, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 126 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 32
- States / cities
- Phoenix, Arizona • Hollywood, Florida • Miami, Florida + 17 more
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
- Interventions
- NT0102, Placebo
- Drug
- Lead sponsor
- Neos Therapeutics, Inc
- Industry
- Eligibility
- 6 Years to 12 Years
- Enrollment
- 87 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 4
- States / cities
- Bradenton, Florida • Maitland, Florida • Las Vegas, Nevada + 1 more
- Conditions
- Postoperative Nausea and Vomiting, Genetic Polymorphisms
- Interventions
- Ondansetron, Lorazepam, Aprepitant
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 21 Years to 70 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 6
- States / cities
- San Francisco, California • Kansas City, Kansas • Lexington, Kentucky + 3 more
- Conditions
- Menstrual Migraine
- Interventions
- Rimegepant, Placebo Comparator, Standard of Care
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 723 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 32
- States / cities
- Phoenix, Arizona • Scottsdale, Arizona • Canoga Park, California + 25 more
- Conditions
- Migraine
- Interventions
- Rimegepant 75mg daily dosing, Rimegepant 75mg every other day dosing, Placebo comparator dosing
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,415 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 30
- States / cities
- Tempe, Arizona • Colton, California • Los Angeles, California + 27 more
- Conditions
- Motor Neuron Disease
- Interventions
- FLX-787-ODT (orally disintegrating tablet), Placebo ODT
- Drug
- Lead sponsor
- Flex Pharma, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 54 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 35
- States / cities
- Scottsdale, Arizona • Sacramento, California • San Francisco, California + 29 more
- Conditions
- Knee Arthritis
- Interventions
- Cannabidiol (CBD), Placebo
- Drug
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 40 Years to 75 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Erectile Dysfunction
- Interventions
- Vardenafil ODT (STAXYN, BAY38-9456), Placebo
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 339 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 21
- States / cities
- Chandler, Arizona • Mesa, Arizona • Phoenix, Arizona + 15 more
- Conditions
- Parkinson's Disease
- Interventions
- Fipamezole ODT, Placebo
- Drug
- Lead sponsor
- Bausch Health Americas, Inc.
- Industry
- Eligibility
- 30 Years to 75 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 4
- States / cities
- Torrance, California • Bingham Farms, Michigan • Willingboro, New Jersey + 1 more
- Conditions
- Concussion Post Syndrome
- Interventions
- Magnesium Oxide, Acetaminophen, Zofran ODT 4 MG Disintegrating Oral Tablet
- Drug
- Lead sponsor
- Corewell Health South
- Other
- Eligibility
- 12 Years to 18 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Saint Joseph, Michigan
- Conditions
- Autistic Disorder
- Interventions
- Fluoxetine, Placebo
- Drug
- Lead sponsor
- Neuropharm
- Industry
- Eligibility
- 5 Years to 17 Years
- Enrollment
- 158 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 17
- States / cities
- Phoenix, Arizona • Sacramento, California • Gainesville, Florida + 14 more